How is BPC-157 arginate different from the usual form?

The arginate salt is intended to improve the peptide's stability and aqueous solubility compared with the more common acetate salt, while the active BPC-157 sequence remains the same.

What does the TB-4 fragment add?

The Thymosin Beta-4 fragment retains the actin-binding region that drives cell migration and tissue remodeling, complementing BPC-157's angiogenic and growth-factor effects.

Is this blend approved for healing injuries?

No. It is a research chemical with no FDA approval; supporting evidence comes from preclinical and component-level studies.

← All peptides

Healing & Recovery

Research Chemical

Repair and Recovery Blend (Stable BPC-157 Arginate, TB-4 Fragment)

Also known as: Repair and Recovery Blend, Healing and Repair Research Blend (BPC-157, TB4 Frag 1-4, GHK-Cu)

A research blend pairing a stabilized arginate salt of BPC-157 with an active fragment of Thymosin Beta-4 to target soft-tissue and musculoskeletal repair. It is studied for accelerated wound healing and recovery.

Mechanism of Action

BPC-157 promotes angiogenesis and tendon/ligament fibroblast outgrowth by upregulating VEGFR2 signaling, the nitric oxide system, and growth-factor receptor expression. The arginate salt form is intended to improve stability and solubility relative to the acetate. The Thymosin Beta-4 N-terminal fragment retains the actin-binding and cell-migration-promoting properties of the parent peptide, supporting cytoskeletal remodeling, keratinocyte and endothelial migration, and reduced inflammation. Together the components target the angiogenic, migratory, and anti-inflammatory phases of healing.

Half-life: Short for BPC-157 (minutes to a few hours in plasma); the TB-4 fragment is cleared on a similar short timescale.
Administration Routes: subcutaneous
Research Status: Research Chemical